Publications by authors named "Cathy Zhou"

Claim this Profile
F
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL.
Jan A Burger, Paul M Barr, Tadeusz Robak, Carolyn Owen, Alessandra Tedeschi, Cathy Zhou

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-read Ribo-STAMP simultaneously measures transcription and translation with isoform resolution.
Pratibha Jagannatha, Alexandra T Tankka, Daniel A Lorenz, Tao Yu, Brian A Yee, Cathy J Zhou

Genome Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study.
Carol Moreno, Isabelle G Solman, Constantine S Tam, Andrew Grigg, Lydia Scarfò, Cathy Zhou

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of LexA enhancer-trap lines in Drosophila by an international scholastic network.
Ella S Kim, Arjun Rajan, Kathleen Chang, Sanath Govindarajan, Clara Gulick, Cathy Zhou

G3 (Bethesda)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Patients with High-Risk Features after Fixed-Duration Ibrutinib plus Venetoclax: Phase II CAPTIVATE Study in First-Line Chronic Lymphocytic Leukemia.
John N Allan, Ian W Flinn, Tanya Siddiqi, Paolo Ghia, Constantine S Tam, Cathy Zhou

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language Summary.
Paul M Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Cathy Zhou

Future Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Tumor Debulking with Ibrutinib Before Initiation of Venetoclax: Results from the CAPTIVATE Minimal Residual Disease and Fixed-Duration Cohorts.
Paul M Barr, Alessandra Tedeschi, William G Wierda, John N Allan, Paolo Ghia, Cathy Zhou

Clin Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.
Constantine S Tam, John N Allan, Tanya Siddiqi, Thomas J Kipps, Ryan Jacobs, Cathy Zhou

Blood· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up to 8-year follow-up from RESONATE-2: first-line ibrutinib treatment for patients with chronic lymphocytic leukemia.
Paul M Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Cathy Zhou

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study.
William G Wierda, John N Allan, Tanya Siddiqi, Thomas J Kipps, Stephen Opat, Cathy Zhou

J Clin Oncol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study.
Richard Greil, Alessandra Tedeschi, Carol Moreno, Bertrand Anz, Loree Larratt, Cathy Zhou

Ann Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Adrenal Collision Tumor in a Patient with Cushing's Syndrome.
Cathy Zhou, Ghaneh Fananapazir, Michael J Campbell

Case Rep Endocrinol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sonographically Diagnosed Urothelial Thickening in Kidney Allografts: A Noninvasive and Clinically Highly Relevant Marker for the Detection of Acute Rejection.
Ghaneh Fananapazir, Shannon M Navarro, Cathy Zhou, Kuang-Yu Jen, Thomas W Loehfelm

AJR Am J Roentgenol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunistic body composition evaluation in patients with esophageal adenocarcinoma: association of survival with F-FDG PET/CT muscle metrics.
Cathy Zhou, Brent Foster, Rosalie Hagge, Cameron Foster, Leon Lenchik

Ann Nucl Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour debulking and reduction in predicted risk of tumour lysis syndrome with single-agent ibrutinib in patients with chronic lymphocytic leukaemia.
William G Wierda, John C Byrd, Susan O'Brien, Steven Coutre, Paul M Barr, Cathy Zhou

Br J Haematol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.
Ramesh K Ramanathan, Gary W Thomas, Alok A Khorana, Satish Shah, Cathy Zhou

Oncology· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib.
Jacqueline C Barrientos, Jan A Burger, John C Byrd, Peter Hillmen, Cathy Zhou

Leuk Lymphoma· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Carol Moreno, Richard Greil, Fatih Demirkan, Alessandra Tedeschi, Bertrand Anz, Cathy Zhou

Lancet Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors.
Cathy Zhou, Zilong Yuan, Weijie Ma, Lihong Qi, Angelique Mahavongtrakul

J Hematol Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2.
Paul M Barr, Tadeusz Robak, Carolyn Owen, Alessandra Tedeschi, Osnat Bairey, Cathy Zhou

Haematologica· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 230 patients with relapsed/refractory deletion 17p chronic lymphocytic leukaemia treated with ibrutinib from 3 clinical trials.
Jeffrey Jones, Anthony Mato, Steven Coutre, John C Byrd, Richard R Furman, Cathy Zhou

Br J Haematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival adjusting for crossover: phase 3 study of ibrutinib . chlorambucil in older patients with untreated chronic lymphocytic leukemia/small lymphocytic lymphoma.
Steven Coutre, Alessandra Tedeschi, Tadeusz Robak, Paul M Barr, Carolyn Owen, Cathy Zhou

Haematologica· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended Treatment with Single-Agent Ibrutinib at the 420 mg Dose Leads to Durable Responses in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Steven E Coutré, Richard R Furman, Ian W Flinn, Jan A Burger, Kristie Blum, Cathy Zhou

Clin Cancer Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre.
Cathy Zhou, Diana L Urbauer, Bryan M Fellman, Pheroze Tamboli, Miao Zhang

BJU Int· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skip and save: utility of pelvic x-rays in the initial evaluation of blunt trauma patients.
Jose Raul Soto, Cathy Zhou, David Hu, Antonio C Arazoza, Ernest Dunn

Am J Surg· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis